logo
Book a meeting
Apath

Apath

Biotechnology, 903 Quarry Rd, New York, 52241, United States, 1-10 Employees

apath.com

  • facebook
  • LinkedIn

Who is APATH

Apath is a privately held technology licensing company founded by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020, engaged in the commercial application of virology and viral genetic...

Read More

lock icon Get Full Access
map
  • 903 Quarry Rd, New York, New York, 52241, United States Headquarters: 903 Quarry Rd, New York, New York, 52241, United States
  • 1996 Date Founded: 1996
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from APATH

Apath Org Chart and Mapping

Employees
Jake Simmons

Jake Simmons

Research Technologiest

See Full Org Chart arrow
email-formate-icon
View Email Formats for Apath
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Apath

Answer: Apath's headquarters are located at 903 Quarry Rd, New York, 52241, United States

Answer: Apath's official website is https://apath.com

Answer: Apath's revenue is $1 Million to $5 Million

Answer: Apath's SIC: 2836

Answer: Apath's NAICS: 541714

Answer: Apath has 1-10 employees

Answer: Apath is in Biotechnology

Answer: Apath contact info: Phone number: Website: https://apath.com

Answer: Apath is a privately held technology licensing company founded by Dr. Charles M. Rice, Nobel Laureate in Medicine 2020, engaged in the commercial application of virology and viral genetics to assist pharmaceutical companies in discovering and developing therapeutic products for the treatment of viral infections. Apath is the premier technology licensing company of research and development tools utilized to validate therapies for the hepatitis C virus, respiratory syncytial virus, Ebola virus, sindbus virus, West Nile virus, and permissive cell line technologies utilized in research surrounding influenza and SARS-CoV-2. We represent multiple academic institutions and commercial entities holding the fundamental intellectual property required for developing HCV and RSV Therapeutics, Antibodies, Vaccines, and SARS-CoV-2-related therapeutics.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access